Cargando…

Can tomato juice be used for prophylaxis in recurrent stone formers?

Detalles Bibliográficos
Autores principales:	Agrawal, Madhu S., Singh, Sanjeet Kumar
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684307/ https://www.ncbi.nlm.nih.gov/pubmed/19468451

Ejemplares similares

Management of multiple/staghorn kidney stones: Open surgery versus PCNL (with or without ESWL)
por: Agrawal, Madhy S., et al.
Publicado: (2009)

Antibiotic prophylaxis in vesicoureteral reflux: A paradigm shift
por: Banerji, J. S., et al.
Publicado: (2009)

Pharmacological prophylaxis for venous thromboembolism: Is it time to change the gold standard?
por: Kumaraswamy, Santosh
Publicado: (2021)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

Does treatment rate impact the efficacy of extracorporeal shock wave lithotripsy for kidney or ureteral stones?
por: Muruganandham, K., et al.
Publicado: (2007)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

Vaginal mucosal vaccine for recurrent urinary tract infections
por: Gautam, Gagan, et al.
Publicado: (2007)

The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
por: Agrawal, Sumit
Publicado: (2020)

Can micturating cystourethrograms be avoided in follow-up of antenatally diagnosed hydronephrosis?
por: Chawla, Arun, et al.
Publicado: (2008)

Can suppressive antibiotics be avoided in the postnatal management of antenatally detected obstructive hydronephrosis?
por: Reddy, Sreedhar V., et al.
Publicado: (2007)

Can early salvage radiotherapy replace adjuvant radiotherapy as the new standard of care for high-risk postradical prostatectomy patients?
por: Pandey, Abhishek
Publicado: (2021)

Increasing use of nephron sparing surgery for T1a renal tumors
por: Kumar, Rajeev
Publicado: (2007)

Triple therapy for metastatic castration sensitive prostate cancer: PEACE-1 trial
por: Singh, Kirti
Publicado: (2022)

Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
por: Singh, Kirti
Publicado: (2023)

Is lap nephrectomy superior to open? A randomized trial
por: Kumar, Anup, et al.
Publicado: (2008)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

PROpel trial: Are PARP inhibitors ready to become the first-line treatment for mCRPC?
por: Gaur, Abhay Singh
Publicado: (2022)

Alfuzosin for chronic pelvic pain syndrome: Another placebo?
por: Nirmal, T. J., et al.
Publicado: (2009)

Does early orchidopexy reduce risk of testicular cancer?
por: Banerji, John S., et al.
Publicado: (2008)

Follow-up after pyeloplasty: How long?
por: Nirmal, T. J., et al.
Publicado: (2008)

Defining the role of antioxidants in the prevention of prostate cancer
por: Pathak, Hemant R., et al.
Publicado: (2009)

Endocrine treatment in advanced prostate cancer: When to start?
por: Choudhrie, A. V., et al.
Publicado: (2009)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Nitrous oxide during anesthesia for laparoscopic donor nephrectomy: Does it matter?
por: Singh, Pratipal, et al.
Publicado: (2008)

A comparison of traditional anterior colporrhaphy, polypropylene mesh and porcine dermis in cystocele repair
por: Singh, Pratipal, et al.
Publicado: (2007)

Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two
por: Grover, S., et al.
Publicado: (2007)

Partial nephrectomy for small renal tumors may prevent chronic kidney disease
por: Kumar, Rajeev
Publicado: (2008)

TITAN trial; shifting focus from hormone-refractory to hormone-sensitive prostate cancer
por: Kumar, Gautam
Publicado: (2020)

LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
por: Kumar, Gautam
Publicado: (2020)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?
por: Kumar, Naveen
Publicado: (2021)

Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057)
por: Kumar, Bhuwan
Publicado: (2021)

ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?
por: Kumar, Naveen
Publicado: (2022)

Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
por: Ranjan, Satish Kumar
Publicado: (2020)

HERO trial: A rescue from injectable androgen deprivation therapy
por: Ranjan, Satish Kumar
Publicado: (2021)

POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma – A standard of care?
por: Ranjan, Satish Kumar
Publicado: (2020)

Fluorodeoxyglucose-positron emission tomography/computed tomography-based chemotherapy dosage adjustment in seminoma: The GETUG SEMITEP trial
por: Dheeroo, Dheeraj Kumar
Publicado: (2022)

Stress urinary incontinence: Sling or colposuspension?
por: Mukha, Rajiv Paul, et al.
Publicado: (2007)

Does antenatal pelvic floor muscle training prevent stress urinary incontinence in primi-gravidae?
por: Gupta, Gaurav, et al.
Publicado: (2009)

Urethral reconstructive surgery: Which catheters are better?
por: Suryavanshi, Manav, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k1v6bpfpq9o6lcdcv0o915hq0s